AAA ATPase p97 inhibitors (University of Pittsburgh/University of California/Leidos Biomedical Research Inc/National Cancer Institute)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAAA ATPase p97 inhibitors (University of Pittsburgh/University of California/Leidos Biomedical Research Inc/National Cancer Institute)
Drug Alias NameUPCD-30206UPCD-30345UPCDC-30245
ClassificationSmall molecules
Mechanisms of ActionTransitional endoplasmic reticulum ATPase inhibitorsMelanotransferrin inhibitors
TargetsTransitional endoplasmic reticulum ATPaseMelanotransferrin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeidos Biomedical Research IncUniversity Of CaliforniaUniversity Of Pittsburgh +[4] 
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A